Therapeutic drug monitoring of vancomycin in patients with infectious complications in traumatology and orthopedics

Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):60-66

​ Borisov A.M., Galankin T.L., Bozhkova S.A., Verbitskaya E.V., Kasimova A.R., Koroleva E.M.
10.36488/cmac.2020.1.60-66
vancomycin therapeutic drug monitoring residual concentration pharmacokinetics SSI
Section
Personal Experience
Type
Original Article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):60-66

Objective.

The purpose of this study was to study the frequency of achievement of target values of vancomycin residual concentration (RC) and to identify the factors influencing this indicator.

Materials and Methods.

A retrospective observational study of vancomycin RC was performed in 471 patients who received vancomycin infusions in the department of purulent surgery of the RSRI of TO named after R.R. Vreden about capillary instillation after major orthopedic operations over the period from 01.01.2014 to 05.31.2016.

Results.

The target RC values on the third day of vancomycin administration reached 12.1% of patients (76.2% below target RC), after correction of the dosing regimen, the target RC was achieved in 20.3% of patients (56.9% below target RC). Multivariate analysis revealed a connection between RC and age (an increase in RC in age patients) and sex (a higher RC in women). In most cases, the prescribed doses of vancomycin corresponded to the recommended, however, the target RC levels of vancomycin were achieved only in a small proportion of patients.

Conclusions.

At the same time, the lowest frequency of reaching target concentrations was observed in young patients. The study proposed a multifactor model of vancomycin RC, on the basis of which it is possible to carry out the best correction of dosing taking into account the factors of age and sex.

Alexey M. Borisov

National Medical Research Center of Traumatology and Orthopedics named after R.R. Vreden, Saint-Petersburg, Russia

Galankin T.L.

Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russia

Svetlana A. Bozhkova

National Medical Research Center of Traumatology and Orthopedics named after R.R. Vreden, Saint-Petersburg, Russia

Verbitskaya E.V.

Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russia

Kasimova A.R.

National Medical Research Center of Traumatology and Orthopedics named after R.R. Vreden, Saint-Petersburg, Russia
Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russia

Koroleva E.M.

National Medical Research Center of Traumatology and Orthopedics named after R.R. Vreden, Saint-Petersburg, Russia

  • 1. Borisov A.M., Bozhkova S.A., Konovalova M.V. Therapeutic drug monitoring of vancomycin in traumatologic and orthopedic patients. Proceedings of the 15th IACMAC international congress on antimicrobial therapy. Moscow, May 22-24, 2013. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2013;15(2 Suppl. 1):16. Russian.
  • 2. Bozhkova S.A., Tihilov R.M., Krasnova M.V., Rukina A.N. Orthopedic implant-associated infection: leading pathogens, local resistance and recommendations for antibiotic therapy. Travmatologija i ortopedija Rossii. 2013;(4):5-15. Russian. DOI: 10.21823/23112905-2013-4-5-15
  • 3. Federal guidelines for the use of medicines (formulary system). Issue XII. M.: 2011, 635-636 p. Russian.
  • 4. Lomaestro B.M. Vancomycin dosing and monitoring 2 years after the guidelines. Expert Rev Anti Infect Ther. 2011;9(6):657-667. DOI: 10.1586/eri.11.46
  • 5. Al-Mulhim F.A., Baragbah M.A., Sadat-Ali M., Alomran A.S., Azam M.Q. Prevalence of surgical site infection in orthopedic surgery: a 5-year analysis. Int Surg. 2014;99(3):264-268. DOI: 10.9738/INTSURG-D-13-00251.1
  • 6. James G.D., Sealey J.E., Alderman M., Ljungman S., Mueller F.B., Pecker M.S., et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens. 1988;1(2):124-131. DOI: 10.1093/ajh/1.2.124
  • 7. Uçkay I., Hoffmeyer P., Lew D., Pitte D. Prevention of surgical site infections in orthopaedic surgery and bone trauma: state-of-theart update. J Hosp Infect. 2013;84(1):5-12. DOI: 10.1016/j.jhin.2012.12.014
  • 8. Bue M., Hanberg P., Koch J., Jensen L.K., Lundorff M., Aalbaek B., et al. Single-dose bone pharmacokinetics of vancomycin in a porcine implant-associated osteomyelitis model. J Orthop Res. 2018;36(4):1093-1098. DOI: 10.1002/jor.23776
  • 9. Waineo M.F., Kuhn T.C., Brown D.L. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion. J Clin Pharm Ther. 2015;40(3):259-265. DOI: 10.1111/jcpt.12270
  • 10. Rybak M.J., Lomaestro B.M., Rotscahfer J.C., Moellering R.C., Craig W.A., Billeter M., et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious diseases Society of America, the American Society of HealthSystem Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49(3):325-327. DOI: 10.1086/600877
  • 11. Neely M.N., Kato L., Youn G., Kraler L., Bayard D., van Guilder M., et al. A prospective trial on the use of trough concentration versus area under the curve (AUC) to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother. 2018;62(2). pii: e02042-17. DOI: 10.1128/AAC.02042-17
  • 12. Young P.Y., Khadaroo R.G. Surgical site infections. Surg Clin North Am. 2014;94(6):1245-1264. DOI: 10.1016/j.suc.2014.08.008
  • 13. Cooper R.A. Surgical site infections: epidemiology and microbiological aspects in trauma and orthopaedic surgery. Int Wound J. 2013;1(Suppl. 10):3-8. DOI: 10.1111/iwj.12179
  • 14. Rostas S.E., Kubiak D.W., Calderwood M.S. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity. Clin Ther. 2014;36(7):1098-1101. DOI: 10.1016/j.clinthera.2014.05.011
  • 15. Kanj W.W., Flynn J.M., Spiegel D.A., Dormans J.P., Baldwin K.D. Vancomycin prophylaxis of surgical site infection in clean orthopedic surgery. Orthopedics. 2013;36(2):138-146. DOI: 10.3928/01477447-20130122-10
Views
0 Abstract
0 PDF
0 Crossref citations
Shared